No Data
Chugai Pharmaceutical, AnyMind ◆ Today's Fisco hot stocks ◆
Chugai Pharmaceutical Co., Ltd. <4519> announced a revision to the financial estimates for the fiscal year ending December 2025. The revenue is revised upward from 1.07 trillion yen to 1.15 trillion yen, and the core operating profit is revised from 460 billion yen to 540 billion yen. For domestic commodity etf revenue, reflecting the progress and reassessment of products such as Fesgo, Polaibee, Babiesmo, and Pajeta. Overseas commodity etf revenue is expected to exceed the previous forecast, mainly due to the export to Roche of Hemlibra and Actemra. AnyMi
AnyMind---Aim for a rebound from the first round of adjustments.
A weak trend continues, dropping to the lowest level since August. Amid the expanding Bollinger Bands, it continues to adjust along the -2σ downward trend. Forming a bottom with the August low is likely to be conscious. In addition, on the weekly Ichimoku Cloud chart, it has fallen below the cloud lower limit due to last week's decline, indicating a deteriorating signal, but it seems likely to aim for a rebound once it completes the adjustment phase.
AnyMind Group Launches GenAI Review Analysis Module for Southeast Asia
AnyMind Group Reports Sustainable Growth and Profitability
AnyMind Group: Answers to frequently asked questions (questions received in the 3rd quarter of 2024)
Task Holdings, LiberaWare, etc.
<166A> Tasaki Holdings Co., Ltd. Unitechs shareholding ratio 5.74% → 4.72% Obligation to report starting on 19 September 2024 <218A> LiberaWare Bonds Investment Group Co., Ltd. shareholding ratio 5.16% → 2.94% Obligation to report starting on 19 September 2024 <4883> Modaris Nuki Co., Ltd. shareholding ratio 5.11% →
No Data
No Data